2013
ShearWave™ Elastography BE1 Multinational Breast Study: Additional SWE™ Features Support Potential to Downgrade BI-RADS®-3 Lesions
Schäfer F, Hooley R, Ohlinger R, Hahne U, Madjar H, Svensson W, Balu-Maestro C, Juhan V, Athanasiou A, Mundinger A, Order B, Locatelli M, Cosgrove D, Wolf O, Henry J, Moutfi M, Gay J, Cohen-Bacrie C. ShearWave™ Elastography BE1 Multinational Breast Study: Additional SWE™ Features Support Potential to Downgrade BI-RADS®-3 Lesions. Ultraschall In Der Medizin - European Journal Of Ultrasound 2013, 34: 254-259. PMID: 23709241, DOI: 10.1055/s-0033-1335523.Peer-Reviewed Original ResearchConceptsMalignancy rateNon-significant increaseLesion groupBI-RADSProspective study populationSWE featuresNumber of lesionsCore biopsyCancer ratesStudy populationLesionsSWE assessmentBenign massesBreast lesionsDiagnostic populationBreast studiesLower increaseUltrasound characterizationE-colorBiopsyMalignancyPopulationShearWaveCytology
2012
Accuracy of breast MRI in predicting pathologic tumor size.
Caprio K, Chagpar A, Hooley R, Tavassoli F, Honarpishe H, Lannin D, Killelea B, Horowitz N. Accuracy of breast MRI in predicting pathologic tumor size. Journal Of Clinical Oncology 2012, 30: 1109-1109. DOI: 10.1200/jco.2012.30.15_suppl.1109.Peer-Reviewed Original ResearchPathologic tumor sizeTumor sizeAccuracy of MRIMRI sizePathologic sizePathology sizeBreast cancerMRI lesion sizeSitu breast cancerPreoperative planning toolFinal pathologyNeoadjuvant chemotherapyPatient agePathologic findingsTumor histologyPreoperative MRILesion sizeLesionsBreast MRISpearman's rho coefficientPatientsMRICancerModest correlationSpearman coefficient